Advertisement

Topics

Latest "Calvert Laboratories" News Stories

02:04 EDT 21st September 2018 | BioPortfolio

Here are the most relevant search results for "Calvert Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about Calvert Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Calvert Laboratories for you to read. Along with our medical data and news we also list Calvert Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of Calvert Laboratories Companies for you to search.

Showing "Calvert Laboratories" News Articles 1–25 of 1,900+

Relevant

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses based on the strength of its dividends, analyst recommendations, institutional ownership, earnings, profitability, valuation and risk. IDEXX Laboratories has higher revenue and earnings than its rivals.


Brokers Issue Forecasts for Impax Laboratories Inc's Q1 2018 Earnings

Impax Laboratories Inc - Analysts at SunTrust Banks issued their Q1 2018 earnings estimates for Impax Laboratories in a report issued on Wednesday. SunTrust Banks analyst J. Boris expects that the specialty pharmaceutical company will earn $0.27 per share for the quarter.

Bionik Laboratories Issues Letter to Stockholders

I joined Bionik Laboratories as CEO in September 2017, having served as a director of the Company for the previous two months.  A focus Read more...


Dr. Reddy's Laboratories Launches Hervycta In India

NewsDr. Reddy’s Laboratories has launched Hervycta, a biosimilar of Roche’s Herceptin, in India, indicated for the treatment of HER2-positive cancers (early breast cancer, metastatic breast cancer, and metastatic gastric cancer).

Chemistry, Spectroscopy Software Features Stereochemical Recognition

Product AnnouncementBio-Rad Laboratories, Inc. announced the release of its KnowItAll software and spectral databases.Contributed Author: 

Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech

Dr. Reddy’s Laboratories has signed a distribution agreement with UCB to supply the latter’s epilepsy drug Briviact in India. As...Read More... The post Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech appeared first on Pharmaceutical Technology.

ACM acquires ABS to accelerate growth driven by clinical trials, toxicology

ACM Global Laboratories has acquired ABS Laboratories to better serve its clients in the clinical trial market with an expanded "scientific acumen," says company president.

FDA Approves First Generic Version Of Suboxone

NewsDr. Reddy's Laboratories announces final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. market.

Discovery Laboratories, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

Discovery Laboratories, Inc. Strategy, SWOT and Corporate Finance ReportSummaryDiscovery Laboratories, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsWindtree Thera...

IDEXX Laboratories Inc Q2 Earnings Rise

WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc (IDXX) released earnings for its second quarter that advanced from last year.The company's profit came in at $108.68 million, or $1.23 per share. This...

Riding bacterium to the bank

(DOE/Sandia National Laboratories) Jet fuel, pantyhose and plastic soda bottles: all three could be made from bioengineered bacteria, as Sandia National Laboratories has now demonstrated.

Morepen Laboratories net jumps by 94% in Q1

Morepen Laboratories has posted impressive financial performance during the first quarter ended June 2018 and its consolidated net profit went up by 93.7 per cent to Rs. 2.46 crore from Rs. 1.27 crore

CloudLIMS? New Client Portal Enhances Customer Service Capabilities of Biobanks and Testing Laboratories

New portal is designed for biorepositories and testing laboratories

Diesel doesn't float this boat

(DOE/Sandia National Laboratories) Marine research could soon be possible without the risk of polluting either the air or the ocean. It's thanks to a new ship design and feasibility study led by Sandia National Laboratories.

Wickham Laboratories to exhibit at Making Pharmaceuticals UK 2018

Wickham Laboratories Ltd will exhibit on Stand 309 at the Making Pharmaceuticals Conference on 24 – 25 April 2018 at Ricoh Arena, Coventry... The post Wickham Laboratories to exhibit at Making Pharmaceuticals UK 2018 appeared first on

Dr. Reddy's Laboratories announces its intent to appeal court decision in preliminary ...

Dr. Reddy’s Laboratories Ltd.INVESTOR RELATIONSSAUNAK SAVLA, +91-40-49002135saunaks@drreddys.comorMEDIA RELATIONSCALVIN PRINTER, +91-40-49002121calvinprinter@drreddys.com Read more...

Zacks: Analysts Expect Impax Laboratories Inc (IPXL) Will Announce Quarterly Sales of $184.90 Million

Equities analysts expect Impax Laboratories Inc to announce sales of $184.90 million for the current fiscal quarter, according to Zacks . Four analysts have made estimates for Impax Laboratories' earnings.

Wickham Laboratories to present at Cleanroom Technology Conference 2018

Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16 May at 2:30PM, at the National Conference Centre in Birmingham... The post

Dr Reddy's Laboratories net jumps to Rs. 456 crore in Q1

Dr Reddy's Laboratories, a Rs. 14,200 crore plus fifth largest Indian phrma major, has posted growth in net profit during the first quarter ended June 2018 on account of launch of new product in US and emerging markets.

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

"Soon-to-be discarded patient samples create an opportunity for laboratories to generate recurring revenue, while iSpecimen's network of laboratories helps researchers gain access to precisely the Read more...

Technical Perspectives on Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer

Impax Laboratories Shares in Hayward, Californiaheadquartered Impax Laboratories Inc. rose slightly by 0.78%, ending Wednesday's trading session at $19.45. The stock recorded a Read more...

Ipca Laboratories' net jumps by 15.9% to Rs. 51 crore in Q4

Ipca Laboratories has posted net profit growth of 15.9 per cent during the fourth quarter ended March 2018 to Rs. 51 crore from Rs. 44 crore in the similar period of last year.

Alkem Laboratories net jumps up by 115% to Rs.137 crore

Alkem Laboratories, a Rs.6,400 crore pharma major, has posted impressive financial performance during the first quarter ended June 2018 and its consolidated net profit went up by 115.2 per cent to Rs.137 crore

Merck to distribute HistoCyte Laboratories’ cell line products

Pharmaceutical company Merck has signed an agreement to become the exclusive multinational distributor of HistoCyte Laboratories’ portfolio of cell line...Read More... The post Merck to distribute HistoCyte Laboratories’ cell line products appeared first on Pharmaceutical Technology.

Abbott Laboratories Strategy, SWOT and Corporate Finance Report [Report Updated: 01052018] Prices from USD $175

Abbott Laboratories Strategy, SWOT and Corporate Finance ReportSummaryAbbott Laboratories Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsAbbott Laboratories Abbott or 't...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks